Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Imidazo[2,1 b]thiazole derivatives. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN113831357A discloses a Lewis acid-catalyzed Michael addition for imidazothiazoles, offering mild conditions and high functional group tolerance for pharmaceutical manufacturing.
Novel Lewis acid catalyzed route offers mild conditions and high purity for complex heterocyclic pharmaceutical intermediates.